Sarah Cannon Research Institute
Shelby Cummins, M.S., is a Clinical Data Analyst at the Sarah Cannon Research Institute since April 2021. Prior experience includes roles as Crossings Program Manager and Certified Nursing Assistant at Brookdale from May 2020 to April 2021, and an internship at Lipscomb University from August 2018 to May 2020, where responsibilities included serving as IDEAL Chapel Coordinator and Joshua Project Coordinator. Shelby holds a Master’s degree in Biomolecular Science and a Bachelor’s degree in Biology, both earned at Lipscomb University.
This person is not in the org chart
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.